openPR Logo
Press release

Histone Methyltransferases Market by Global Industry Research 2019

01-09-2017 06:25 AM CET | Health & Medicine

Press release from: TMR- Research Reports

Histone Methyltransferases Market by Global Industry Research

Histones are the major protein constituents of eukaryotic nucleus. Histone methyltransferases catalyzes the transfer of methyl group to lysine and arginine residues of the histone protein. It catalyzes the reaction with the help of SN-2 mechanism where transfer of methyl group from S Adenosyl Methionine to amino group of target lysine takes place. There are seven histone methyltransferase includes EZ, SET1, SET2, SMYD, SUV39, SUV4-20 and RIZ. The main function of histone methyltransferase includes gene regulation. Histone methyltransferases is also used as a biomarker for the diagnosis of cancer.

Request a PDF Brochure with Report Analysis: http://bit.ly/2iPCHdK

Growing prevalence of various cancers such as breast, lung, prostate and blood cancer accentuates the growth of histone methyltransferase market globally as they are widely utilized as a diagnostic option for the treatment of cancer. Moreover, increasing research and development activities for cancer drug development also accentuates the global market; as histone methyltransferase is utilized as a biomarker for the above mentioned studies. However, high cost and technological complexities associated with histone methyltransferase might hinder the demand globally.

Geographically North America dominates the global market histone methyltransferase with increasing awareness among people about histone methyltransferase. Europe represents the second position of the global market with rising prevalence of geriatric population. Asia-pacific holds the third largest share and is regarded as an emerging market and is expected to grow at a highest CAGR during the study period 2013 to 2019. RoW is considered as an intact market for histone methyltransferase due to less awareness among the people.

Various key players contributing to the global histone methyltransferases market comprises Bellbrook Labs, Cayman Chemical Company, Celgene Corporation, Cell Signaling Technology, Inc., Cisbio U.S., Constellation Pharmaceuticals, Diagenode Inc. USA, Boehringer Ingelheim GMBH, Domainex, Eisai Co., Ltd., Cellcentric Ltd and EMD Group (EMD Millipore).

Browse Full Research Report on Histone Methyltransferases Market:
http://www.transparencymarketresearch.com/histone-methyltransferases-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Histone Methyltransferases Market by Global Industry Research 2019 here

News-ID: 407536 • Views:

More Releases from TMR- Research Reports

Healthcare Mobility Solutions Market Advancements in Wireless Networks to Drive Adoption 2024
Healthcare Mobility Solutions Market Advancements in Wireless Networks to Drive …
Focus on Reducing Healthcare Costs Drives Global Market The constantly growing and evolving medical needs have been the driving force behind the evolution of healthcare mobility solutions. The aim of these solutions is to reduce the healthcare costs and to provide the patients an optimum solution in the least possible time. The simplicity of this objectivity has been successfully achieved by the development of healthcare mobility solutions’ products and services such
Global District Heating and Cooling Market: Big Players Foraying into Manufacturing likely to Up Competition, finds TMR
Global District Heating and Cooling Market: Big Players Foraying into Manufactur …
To gauge the competitive dynamics in the global district heating and cooling (DHC) market, the DHC system manufacturers, project contractors, and plant operators in the supply chain will have to be factored in, states a report by Transparency Market Research (TMR). In the coming years, big plant operators and private operators are predicted to start manufacturing DHC systems, which in turn, would likely heat up the competition. Competition would also
Condiment Sauces Market is Expected to Exhibit a positive CAGR of 3.2% from 2014 through 2020, and Rise to nearly US$23.40 bn by 2020
Condiment Sauces Market is Expected to Exhibit a positive CAGR of 3.2% from 2014 …
Condiment sauces are used in food to enhance taste, flavor or as a complimentary item in different dishes. It is used either as table dips or in cooking or as both. The condiments sauces market has experienced a diversified trends across different regions such as North America, Europe, Asia Pacific and RoW. The Global condiment sauces market is expected to witness rapid changes due to fast changing eating patterns across
Active and Modified Atmosphere Packaging Market Rises With Growing Consumer Dema …
In the presence of normal air, food products such as meat, poultry, fish, fruits, vegetables, and bakery products perish quickly due to biochemical reaction of oxygen with products, and the growth of microorganisms, which degrade the product quality. The biochemical reactions or effects of microorganisms tend to change the color, taste, texture, and smell of the product leading to overall deterioration in the quality of product. Cold storage facilities, for sure,

All 5 Releases


More Releases for Histone

Global Histone Deacetylase Inhibitors Market Research Report
This report studies the global Histone Deacetylase Inhibitors market status and forecast, categorizes the global Histone Deacetylase Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report 4SC AG Acetylon Pharmaceuticals Celleron Therapeutics Chroma Therapeutics CrystalGenomics Curis MEI Pharma Mirati Therapeutics Novartis
Histone Methyltransferases Market Growth Analysis 2019
Histones are the major protein constituents of eukaryotic nucleus. Histone methyltransferases catalyzes the transfer of methyl group to lysine and arginine residues of the histone protein. It catalyzes the reaction with the help of SN-2 mechanism where transfer of methyl group from S Adenosyl Methionine to amino group of target lysine takes place. There are seven histone methyltransferase includes EZ, SET1, SET2, SMYD, SUV39, SUV4-20 and RIZ. The main function
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase Inhibitors Market & Pipeline Insight2015
Histone Deacetylase (HDAC) are enzymes responsible for removal of acetyl groups present on acetyl lysine amino acid attached to histone. They are responsible for gene expression and regulation which is responsible for cellular functioning. It also helps in wrapping of histone over the Deoxyribonucleic acid (DNA). They are involved in cell growth and death which is responsible for maintaining steady state. Their involvement in diseases has been noted by investigators
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline …
The latest report Histone Deacetylase 4 - Pipeline Review, H1 2017, outlays comprehensive information on the Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviewsalso reviews key players involved in Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) targeted therapeutics development